Advanced searches left 3/3
Search only database of 8 mil and more summaries

Physical Mutations In Humans

Summarized by PlexPage
Last Updated: 02 July 2021

* If you want to update the article please login/register

General | Latest Info

No; only a small percentage of mutations cause genetic disordersamost have no impact on health or development. For example, some mutations alter a gene's DNA sequence but do not change the function of protein made by the gene. Often, gene mutations that could cause genetic disorder are repaired by certain enzymes before a gene is expressed and an altered protein is produce. Each cell has a number of pathways through which enzymes recognize and repair errors in DNA. Because DNA can be damaged or mutate in many ways, DNA repair is an important process by which the body protects itself from disease. A very small percentage of all mutations actually have a positive effect. These mutations lead to new versions of proteins that help an individual better adapt to changes in his or her environment. For example, beneficial mutation could result in protein that protects individuals and future generations from new strains of bacteria. Because a person's genetic code can have large number of mutations with no effect on health, diagnosing genetic conditions can be difficult. Sometimes, genes thought to be related to particular genetic condition have mutations, but whether these changes are involved in development of condition has not been determine; these genetic changes are known as variants of unknown significance or. Sometimes, no mutations are found in suspected disease - related genes, but mutations are found in other genes whose relationship to particular genetic condition is unknown. It is difficult to know whether these variants are involved in disease. The University of Utah Genetic Science Learning Center provides information about genetic disorders that explains why some mutations cause disorders but others do not. The National Human Genome Research Institute provides information about human genomic variation. Cold Spring Harbor National Laboratoryas DNA From Beginning explains the discovery of DNA repair mechanisms in cells and introduces researchers who are working to understand these mechanisms. Force explains the significance of variants of unknown significance in cancer.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

The Human Germline Mutation Rate

Germline mutations are the origin of genetic variation and are widely considered to be the driving force of Genome evolution. Rates and spectra of de novo mutations directly affect evolutionary speed and direction and thereby establish species - specific genomic futures in the long term. This has resulted in keen interest in understanding the origin of germline mutations in mammals. Accumulating evidence from next - Generation sequencing and family - base Analysis indicates that the frequency of human DNMs varies according to sex, age and local genomic context. Thus, it is likely that there are multiple causes and drivers of mutagenesis, including spontaneous DNA lesions, DNA repair status and DNA polymerase errors. In this review, recent studies of human and mouse germline DNMs are discuss, and rates and spectra of spontaneous germline DNMs in mouse mutator lines Pold1 exo / exo and TOY - KO are summarized in the context of endogenous causes and mechanisms. In mammals, certain number of mutations occur spontaneously and accumulate in both somatic and germline cells throughout the lifetime of an individual. In somatic cells, accumulated mutations increase the risk of cancer and other diseases. Crucially, only mutations that occur in germline cells can be transmitted to offspring and may spread in the population in later generations. Important questions must be address. Are there any differences between cell types regarding maintenance of genome integrity? What are the causes and mechanisms of spontaneous mutation in both cell types? Answers to these questions may provide clues to further understanding Genome evolution in mammals. In theory, soma and germ cells are expected to share some factors and mechanisms of DNA replication and repair because all cells in the body are derived from single zygote. Both types of cells further undergo multiple rounds of DNA replication and mitosis during development. Consequently, environmental conditions or physical states that promote somatic mutations may also increase the incidence of germline mutations. However, even under similar mutagenic conditions, outcomes may differ because DNA damage response and regulation of cell cycle checkpoints and cell death pathways may vary between cell types. Although it is unclear whether germline cells possess specific systems that prevent mutations, several studies have reported that germline cells acquire mutations less frequently than somatic cells. Eukaryotic cells possess a highly accurate DNA replication system that involves nucleotide selectivity and proofreading activity of DNA polymerases and a highly efficient mismatch repair system, such that mutation rate is maintained AT very low level, typically ~10 9 - 10 10 mutations per nucleotide pair per replication. However, despite this highly accurate replication system, considerable number of somatic mutations are generated because numerous DNA replications occur in order to produce large number of cells over the lifetime of mammal. For example, human body consists of approximately 10 14 cells and undergoes approximately 10 16 cell divisions in lifetime, resulting in over 10 15 cumulative mutations per individual. Mutation burden borne by organs in the human body over its lifetime was previously summarize.


Introduction

Germline mutations are the source of heritable differences among individuals. They arise from accidental changes to genome that occur in development of future parent,s in cell lineage from zygote to gamete, either as errors in replication or due to damage that is improperly corrected or uncorrected by the next round of DNA replication. The number of de novo mutations in offspring is thus aggregate over outcomes of mutational processes that play out from zygote to primordial germ cell and across cell states of paternal and maternal gametogenesis. Interestingly, rate at which DNMs are introduced each generation varies substantially among species: As illustration, across vertebrates surveyed to date, per base pair per - generation mutation rates span order of magnitude. Analyses of DNM and polymorphism data further indicate that in addition to the total rate, proportion of each mutation type also varies among mammalian species and even across human populations. The composite nature of per - generation mutation rate allows for many possible explanations for these observations. At the cellular level, damage rates to which species are exposed can change over time, As can repair and replication efficiencies. Cellular composition of germline may also evolvefor example, number of replications per generation. Shifts in any of these components can alter the overall mutation rate. These changes could occur by chance, by genetic drift, or due to natural selection on mutation rate itself. Indeed, mutation rate is not only input to heritable differences but itself phenotype, subject to genetic drift and selection. Mutation rates may also evolve as byproduct of changes in the life history of species, eg, ages at which males and females typically reach puberty and reproduce. Because the life history of species modulates length of exposure of germ cell lineage to distinct developmental stages, shifts in life history can lead to evolution in per - generation mutation rate and spectra. Variants of this model have long been invoked to explain the observation that shorter - living mammalian species tend to have higher rates of neutral substitutions per unit time than longer - living ones. The Generation time effect means that species that are shorter live accrue more mutations per unit time because they undergo more cell divisions per unit time. Although other correlate traits have been proposed to explain the observed dependence between reproductive span and mutation rates per unit time, in mammals, generation time remains the strongest predictor. Evaluating these possible explanations requires comparative data on germline mutation from closely related species that share much of their developmental program but differ in some key features. In principle, such data is now straightforward to collect, by resequencing genomes from tissue samples of mother, father, and child and estimating the number of DNMs that occur in that one generation.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Somatic Mutation

Dna damage and DNA mutations. Erroneous repair of different types of DNA damage that occur in Cells under physiological conditions can result in multiple types of mutations, including chromosomal Mutations, Copy Number Variation, structural Variation, retrotransposition, and Single nucleotide Variation. There are great many different types of DNA damage and only a few examples are give. Only rarely do we know exact types of mutation that can result from erroneous repair of particular lesion. An example is 8 - oxoguanine, common oxidative DNA lesion, which typically generates G: CT: transversions via mispairing with during DNA replication. We also know that genome structural variations can result from DNA DSBs. Mutations, most notably Aneuploidy, which occur as a consequence of mitotic errors, do not necessarily require DNA damage but can be induced spontaneously. Abbreviations: 8 - OxodG, 8 - oxo - 2deoxyguanosine; DSB, double - strand break; L1, LINE - 1; mRNA, messenger RNA; N 3 MeA, N 3 - methyladenine; O 6 MedG, 6 - O - methyldeoxyguanosine; SSB, Single - strand break. Single - cell Analysis detects Somatic Mutations. Using bulk Sequencing, Somatic SNVs and deletions cannot be detected because they are unique to cell and, consequently, affect only one out of many thousands of reads. Snvs cannot even be distinguished from Sequencing errors, which occur at much higher frequency than Somatic Mutations, ie, 1 / 100. These low - abundant SNVs and deletions can only be detected using Single - cell Sequencing, through which heterozygous Mutations will be observed in approximately half of reads. Both AG Mutation and deletion are now easily identify. Germline variants are detectable in all single cells and in bulk DNA. Abbreviations: SNP, Single - nucleotide polymorphism; SNV, Single nucleotide Variation, WGA, whole - Genome amplification. Somatic Mutations accumulate with age in four different tissues of mouse. A transgenic mouse model harboring chromosomally integrated plasmids containing lacZ reporter gene was used. Plasmids were excise and transferred into Escherichia coli to select for mutants that inactivate lacZ - encode beta - galactosidase. Using this model, mutation frequency was determined in the brain, heart, liver, and small intestine as function of the age of animals. Each determination point is average of at least five individual mice. Rate of age - related Mutation accumulation in four tissues. Abbreviation: bp, base pair. Data from References 28 and 30. Mutations may contribute to cellular functional decline during aging. In young organism, substantial number of mutations have already accumulate, for example, as replication errors during very high rate of cell division that occur during development. These mutations may affect the function of cells in different organs and tissues, but they are not significant enough to affect organism from operating optimally. During aging, mutations accumulate further and quickly begin to exceed the threshold for functioning optimally, which has been set low since there is no selective advantage in maintaining genome integrity for much longer than the age of first reproduction. Hence, there are more and more cells that suffer functional decline and even death. Occasionally, particular combinations of mutations affect growth restraint, and such cells grow into hyperplastic or neoplastic lesions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Altered Fates of Deleterious Mutations

Although humans are unexceptional with respect to mutational features, human conditions impose unusual influences on the fates of deleterious germline mutations. On one hand, for case of genetic disorders involving one to few loci with major effects, combination of genetic screening and counseling can reduce transmission of deleterious alleles across generations. But on the other hand, because the vast majority of heritable mutations have very minor effects, and because we are all born with large numbers of them, they are for the most part recalcitrant to identification of their individual effects. This means that the myriad of clinical procedures for mitigating consequences of bad genes can only result in relaxation of natural selection against a broad class of deleterious mutations. The sensitivity of incidence of deleterious mutations under both of these scenarios can be evaluated by considering the underlying model for allele - frequency dynamics. Alleles with discernible deleterious effects are generally maintained at low frequencies by balance between recurrent input by mutation and removal by selection. Letting u 0 be the historical mutation rate to deleterious alleles per generation and S 0 be the historical magnitude of selection against allele, expected equilibrium frequency is simply {matheq}{endmatheq} which is closely approximated by u 0 / S 0 providing S 0 u 0. Changes in mutation rate and / or selection coefficient to u N and S N will yield new equilibrium expectation of {matheq}{endmatheq} which is approached asymptotically over time, First, consider the situation for genetic disorder involving mutations with major enough effects to be subject to direct screening in parents and / or early - stage embryos. Assuming an extreme situation in which fraction F of the population is accurately screened for mutation, with carrier chromosomes being culled upon detection, and no other fitness modifications in unscreened individuals, then S N = S 0 + F. Heterozygous effect of deleterious mutation is commonly on the order of S 0 0. 01, so in this case, the policy of 20% screening would lead to {matheq}{endmatheq} assuming the rate of mutation is much smaller than strength of selection, This implies a resultant 21 - fold reduction in new equilibrium allele frequency. From the preceding expression, it can be shown that P T reaches the halfway point to new equilibrium after 0. 7 / S N generations and 90% mark after 2. 3 / S N generations, which become 3 and 11 generations in this particular example. Thus, even a moderate level of genetic screening can be quite effective in lowering the incidence of major disease gene,ss but unless such culling is continuous, recurrent mutation will drive allele frequencies back to their prior levels. Now consider the effect of diminished selection on mutations with small enough effects to be impervious to detection by genetic screening but subject to amelioration by medical intervention.


1. Introduction

Climate change and pressure from human activities such as hunting cause profound changes in the population and demographic structure of many species. 1. This is because extinction events and subsequent recolonization severely alter genetic makeup 2. Demographic changes have important consequences for wildlife management and conservation of endangered species 2 including raising the risk of genetic disorders 3 4 5 6 7 8 9. However, nearly all plant and animal populations, including humans, suffer from temporary reductions in population sizeso - call bottlenecks. Bottlenecks increase genetic drift and inbreeding, which lead to loss of genetic variation, reduce efficacy of natural selection, and increase expression of deleterious recessive mutations 10 11 12. Expression of recessive mutations under inbreeding creates potential for selection to act against these mutations. This process, know as purging, reduces the frequency of deleterious mutations depending on degree of dominance and magnitude of deleterious Effects 13. Because purging depends on levels of inbreeding, bottlenecks tend to purge highly deleterious, recessive mutations unless population sizes are extremely low 13 14 15. Bottlenecks also increase genetic drift and reduce efficacy of selection 16. This allows mildly deleterious mutations to drift to substantially higher frequencies 4 6 17. Hence, bottlenecks generate complex dynamics of deleterious mutation frequencies due to independent effects of purging and reduced selection efficacy 13 14 15 18 19. A major gap in our understanding is how reduced selection efficacy and purging jointly determine mutation load in wild populations. Theoretical predictions are well established 13 15 18 20 but empirical evidence is conflicting 7 9 21 including for humans. Previous research uses changes in fitness to infer possible purging events 7 20 31 32 33, but changes in fitness can result from causes unrelated to purging 12 34. Direct evidence for purging exists only for isolated mountain gorilla populations that split off larger lowland populations ~20 000 years ago 35. However, it remains unknown how recent, dramatic bottleneck events on scale caused by human activity impact levels of deleterious mutations in the wild. Here, we take advantage of exceptionally well characterized repeat bottlenecks during reintroduction of once near - extinct Alpine ibex to retrace the fate of deleterious mutations. Alpine ibex were reduced to ~100 individuals in the 19th century in single population in the Gran Paradiso region of Northern Italy 36. In less than a century, census size of ca. 50 000 individuals have been re - established across the Alps. Thus, population bottleneck of Alpine ibex is among the most dramatic record for any successfully restored species. Recolonization efforts focus on founding local populations across distinct mountain ranges with very limited opportunities for gene flow. Some successfully established populations were used to initiate secondary or tertiary populations elsewhere. As a consequence, most extant populations experience two to four, well - recorded bottlenecks leaving strong footprints of low genetic diversity 37 38. We find exceptionally low genome - wide variation and accumulation of deleterious mutations in Alpine ibex compared to most closely related species.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

The Long-Term Prognosis

Whole genome sequencing data. Align sequencing reads and variant calls are available under controlled access at SRA and dbGaP, with accession phs001872. V1. P1. Files describing de novo mutations observed in Generation II individuals and attributed to germlines of Generation I individuals have been deposited on GitHub at https: / GitHub. Com / quinlan - lab / ceph - dnm - manuscript 40. Life history and clinical outcomes data. Utah Population Database data contributed to this project using birth and death records and family data that include protected health information and individual identifiers. Special attention is given to protecting individuals and their information contained within UPDB and organizations that contribute data while also allowing access to researchers. Accordingly, Utah Resource for Genetic and Epidemiologic Research, established in 1982 by Executive Order of the Governor of Utah, administers access to UPDB through review process of all proposals using UPDB data. Protection of privacy and confidentiality of individuals represented in these records has been negotiated with agreements between RGE and data contributors. Data from UPDB is available only for approved Health - related Research studies and access is project - specific and granted after review and approval by the RGE oversight committee and University of Utah IRB. This process allows researchers with approved protocols to use data, process that has proven effective and successful as evidenced by hundreds of approved studies that have relied on UPDB. Editors and reviewers of our manuscript who feel that they need access to UPDB source data beyond that which is contained in the manuscript, in order to evaluate our study, are requested to contact the corresponding author. Once those needing access sign the RGE Confidentiality Agreement and request for data access is promptly reviewed and approve, access to relevant data will be grant. Code for mortality, cancer incidence, and fertility analyses. This is provided at the end of Supplementary Information.


2. Mutations

Mutations are caused by physical changes to hereditary material and, because DNA is a long sequence of base pairs organized into physically unlinked chromosomes, there are many possible ways it can change. There are point mutations that change only single letter and lead to so - called single nucleotide polymorphisms in populations, insertions and deletions of various sizes, transpositions that move sequence from one position to another, and can thereby cause mutations at boundaries, inversions of various sizes that change orientation of stretch of DNA, chromosome mutations that affect long enough pieces of DNA to become visible under microscope and might even lead to loss or duplication of whole chromosome, and changes in ploidy level, where whole copy of genome is either gain or lose. Special class of mutations is caused by transposable elements. As reviewed in this themed issue by Lee & Langley, there are various types of these elements that can move around in the genome and can copy, insert or excise themselves, sometimes in response to conditions such as stress. Mechanisms exist to control the frequency of transposition events to limit damage from resulting deleterious mutations. At each level, biochemical factors are such that some types of changes occur more frequently than others. For example, in many species there are many more transitions than transversions, methylation of CpG sites in mammals leads to about tenfold higher mutation rates at these sites and the ratio of insertions to deletions can differ among species. Mutation rates are difficult to measure because events are so rare that it is like measuring the frequency of needles in haystacks. Historically, this has been accomplished mainly by finding single genes or groups of genes that lead to phenotypic changes that can easily be observed in populations with known descent and extrapolating to level of genomes. As Kondrashov & Kondrashov point out in their contribution to this issue, recent advances in post - genomic sequencing technology have led to breakthroughs that now allow direct determination of mutation rates in species with sequenced genomes, work which Charlesworth has stimulated by his developments of theory and to which he has contribute directly. Future work in this area is important because accurate estimates of mutation rates at different sites and in different species can be important for testing alternative theories. Mutations are frequently classified as non - synonymous or synonymous according to whether or not they change amino acid sequence, which depends entirely on the function of the mutated base pair. They are easy to recognize and so are frequently used in population genetic tests. They provide useful rules of thumb: eg synonymous sites often evolve neutrally or under weak selection and non - synonymous sites are often under strong purifying selection, even if its strength is difficult to quantify.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

8. Super Vision

Bbs can be caused by changes in more than 20 different genes. It is usually inherited as an autosomal recessive condition. Below you will find a more technical description of genetic changes that underlie BBS and know clinical associations. There are many gene mutations that are known to lead to the development of BBS, some of which are below. Bbs1, BBS2, ARL6, BBS4, BBS5, MKKS, BBS7, TTC8, BBS9, BBS10, TRIM32, BBS12, MKS1, CEP290, WDPCP, SDCCAG8, LZTFL1, BBIP1, IFT27, IFT72, and C8ORF37. Despite the great number of genes already identified as being associated with BBS, gene mutations have not been identified in an estimated 20 - 30 percent of individuals with BBS. There is, moreover, no clear link between different mutations identified and disease severity, but some trends have emerge. Patients with mutations in BBS1 gene seem to have milder ophthalmologic involvement. In comparison, patients with mutations in BBS2, BBS3 and BBS4 genes experience classic deterioration of their vision. Patients with mutations in BBS10 gene generally have significantly increased tendency to obesity and insulin resistance. Human DNA is organized into genes that contain instructions cells need to produce proteins. Proteins are major building block of the human body. Mutations in different genes can result in dysfunctional proteins or insufficient amounts of protein. Most of genes associated with BBS encode proteins called cilia and related structures called basal bodies. Cilia are tiny hair - like structures that cover different types of cells in the body. Basal bodies are architectural elements which anchor cilia to cell. Cilia are classified as motile or immotile. Motile cilia help in beating of fluids through local environment. Immotile cilia function as in sensory processes. Immotile cilia are also required for normal health and development of the body. In BBS, it appears that gene mutations generally affect immotile cilia. Certain symptoms associated with BBS can be attributed specifically to ciliary dysfunction. These features include classic cone - rod dystrophy and renal abnormalities previously discuss, as well as less commonly see, anosmia, hearing loss, and situs inversus. Situs inversus is a term used to describe a condition wherein major body organs exist in mirror image to expect anatomy. Other symptoms associated with BBS cannot clearly be attributed to ciliary dysfunction and active research in this domain is on - going. Bbs is usually inherited in autosomal recessive pattern. Recessive genetic disorders manifest when an individual inherits two abnormal alleles for gene. If an individual receives one normal allele and one mutated allele, person will be carrier for disease, but usually will not present with symptoms. The risk for two carrier parents to both passing altered genes and, therefore have affecting child, is 25% with each pregnancy. The risk of having a child who is a carrier of illness like parents, is 50% with each pregnancy.


What is Stargardt disease?

Genes are bundled together on structures called chromosomes. One copy of each chromosome is passed by parent at conception through egg and sperm cells. X and Y chromosomes, know as sex chromosomes, determine whether a person is born female or male and also carry other non - sex traits. In autosomal recessive inheritance, it takes two copies of mutant gene to give rise to disease. An individual who has one copy of recessive gene mutation is know as carrier. When two carriers have a child, there is: 1 in 4 chance of having a child with disease, 1 in 2 chance of having a child who is a carrier 1 in 4 chance of having a child who neither has disease nor is a carrier in autosomal dominant inheritance, It takes just one copy of mutant gene to bring about Disease. When an affected parent with one dominant gene mutation has a child, there is a 1 in 2 chance that the child will inherit disease. Autosomal recessive mutations in ABCA4 gene account for about 95 percent of Stargardt Disease. Another five percent of cases are caused by rarer mutations in different genes that play a role in lipofuscin function. Some of these mutations are autosomal dominant.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

The Unusually Well

Heart disease is one of the scourges of industrialized countries. It's legacy of the evolutionary past which program us to crave energy - dense fats, once rare and valuable source of calories, now source of clogged arteries. But there's evidence that evolution has the potential to deal with it. All humans have a gene for protein called Apolipoprotein AI, which is part of the system that transports cholesterol through the bloodstream. Apo - AI is one of the HDLs, already known to be beneficial because they remove cholesterol from artery walls. But a small community in Italy is known to have a mutant version of this protein, named Apolipoprotein AI - Milano, or Apo - AIM for short. Apo - AIM is even more effective than Apo - AI at removing cholesterol from cells and dissolving arterial plaques, and additionally functions as antioxidant, preventing some of the damage from inflammation that normally occurs in arteriosclerosis. People with the Apo - AIM gene have significantly lower levels of risk than the general population for heart attack and stroke, and pharmaceutical companies are looking into marketing an artificial version of the protein as a cardioprotective drug. There are also drugs in the pipeline based on different mutation,ss in a gene called PCSK9, which has a similar effect. People with this mutation have as much as 88% lower risk of heart disease. One of the genes that governs bone density in human beings is called low - density lipoprotein receptor - related protein 5, or LRP5 for short. Mutations which impair the function of LRP5 are known to cause osteoporosis. But different kinds of mutation can amplify its function, causing one of the most unusual human mutations know. This mutation was first discovered fortuitously, when a young person from a Midwest family was in a serious car crash from which they walked away with no broken bones. X - rays found that they, as well as other members of the same family, had bones significantly stronger and denser than average. In fact, they seem resistant not just to injury, but to normal age - related skeletal degeneration. Some of them have benign bony growths on the roof of their mouths, but other than that, condition has no side effects - although, as the article notes dryly, it does make it more difficult to float. As with Apo - AIM, some drug companies are researching how to use this as basis for therapy that could help people with osteoporosis and other skeletal diseases. A classic example of evolutionary change in humans is a hemoglobin mutation named HbS that makes red blood cells take on a curved, sickle - like shape. With one copy, it confers resistance to malaria, but with two copies, it causes the illness of sickle - cell anemia. This is not about that mutation. As reported in 2001, Italian researchers studying the population of the African country of Burkina Faso found protective effects associated with different variants of hemoglobin, named HbC. People with just one copy of this gene are 29% less likely to get malaria, while people with two copies enjoy a 93% reduction in risk.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Pathways to Therapeutics

The Ataxia telangiectasia gene plays a key functional role in cells ' response to DNA damage. It encodes PI3 K - related Protein kinase that is involved in activating cellular responses to DNA double - strand breaks via phosphorylation of key factors in DNA damage - response pathway. Individuals harboring one copy of ATM associated with gene deletion in each cell are at high risk of BC; subsequently, cells with missed one copy of this gene are capable of providing half the normal amount of ATM Protein, that leads to prevention of proper repair of DNA damage, resulting in occurrence of mutations in other genes. Germline Mutation in ATM gene has been estimated to attributed to a prevalence of around 0. 5%. It was estimated that heterozygous carriers of ATM mutations have twofold higher breast cancer risk. An increasing body of evidence indicates that this risk can be elevated in women under the age of 50 years. Women harboring ATM C. 7271 T as pathogenic Mutation may confer higher BC risks, although it can be debatable because of limited evidence. There is increasing evidence of radiosensitivity in ATM Mutation carriers regarding mice models and in vitro experiments. Atm mutations are likely linked to increased level of sensitivity to platinum - base antineoplastic drugs. In addition, inhibition of DDR kinases, such as ATM and ATR, has been revealed to increase response to ionizing radiation in some kinds of cancer, including ovarian and cervical carcinoma in vitro, while was not capable of increasing response to platinum drugs. Furthermore, BRCA1 is markedly involved in homologous recombination in primary mouse somatic cells, but not ATM. It is not worthwhile that further clarification will require systematic and in - depth understanding of platinum sensitivity and ATM - aberrant cancers. Contradictory results have been reported regarding radiotherapy in carriers of pathogenic ATM variant where emerging data has indicated increased toxicity, and other evidence indicates clinical benefits. However, high risk has been reported for contralateral breast Cancer in subjects with ATM missense mutations who underwent radiotherapy, indicating lack of proper treatment with radiotherapy. Targeting ATR can be taken into consideration, where single - agent ATR Inhibitors are revealed to be potential therapeutic agents for mantle Cell lymphoma with ATM - deficiency. Accumulating evidence demonstrates that ATR - checkpoint kinase 1 pathway can be considered as potential therapeutic strategies for ATM - deficient cancers. Ve821, VE822, and AZD6738 are ATR Inhibitors which are used in preclinical studies. Azd6738 is analogue of AZ20 that exhibits single - agent anti - Tumor activity across Cancer Cell lines in ATM - deficient. Azd6738 is currently applied in subjects suffering from solid tumors as a single - agent and / or in combination with palliative radiotherapy. Single agent activity of PARP Inhibitors has been demonstrated in ATM - deficient Tumor cells. Base on available data, loss of both ATM and p53 function results in an increased level of PARP cytotoxicity. However, to the best of our knowledge, PARP Inhibitors have not been clinically investigated in ATM - deficient tumors.


Introduction

Several risk factors were recognized to be associated with breast cancer development, including age, hormonal, reproductive, menstrual history, alcohol, radiation, hereditary factors, obesity, etc. Among these risk factors, age is the biggest risk factor for developing breast cancer followed by positive family history. Base on data presented in literature, previous studies discovered several features of inherited mutations in genes. It was estimated that about 10 - 30% of breast cancer cases are related to hereditary factors, also 5 - 10% of breast cancers were detected with strong hereditary factors, while between 4 and 5% of these cases were identified by mutations in high - penetrant genes. Brca1 and BRCA2 have been known as regulators of DNA repair, transcription, and cell cycle in reply to DNA damage. Brca1 and BRCA2 genes are the most commonly mutated genes that are associated with high breast cancer risk. It has been reported that 60% of hereditary breast cancers can be related to germline mutations in either of these genes. A number of genes are associated with multiple Cancer syndromes, For example phosphatase and tensin homolog protein, TP53, STK11 / LKB1, ataxia telangiectasia, and NBS1, but other genes associated with hereditary breast Cancer are emerging. Cancer predisposing genes can be classified as high - penetrant genes including BRCA2, BRCA2, TP53, STK11, and CDH1. On the other hand, majority of gens can be categorized as moderate - penetrant genes in most breast cancer cases, including CHEK2, ATM, CDH1, NBS1, BRIP1, PALB2, BARD1, RAD50, and RAD51, which are frequently mutated in the general population and contribute to the development of breast cancer. The present study tries to focus on the spectrum of mutations, polymorphisms, and variants in each gene which are linked to breast cancer as well as how it contributes to the disease.


Discussion

Despite its current status as the dominant organism on earth, human species is confronted with substantial mutational challenges imposed by at least three baseline genetic features: relatively high per - generation germline mutation rate at nucleotide level; further inflation in mutational rate of production of defective alleles associated with aspects of gene structure; and large cumulative burden of somatic mutations impose by relatively late onset at maturity. Preceding results will now be used to obtain quantitative perspective on these three issues, as well as evaluation of longer - term consequences of mutational and environmental landscape for future genetic well - being of our species.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

What Is a Gene?

Heredity is the passing of genes from one generation to the next. You inherit your parents ' genes. Heredity helps to make you the person you are today: short or tall, with black hair or blond, with brown eyes or blue. Can your genes determine whether you 'll be a straight - student or a great athlete? Heredity plays an important role, but your environment also influences your abilities and interests. People can have changes in genes that can cause many problems for them. Sometimes changes cause little differences, like hair color. Other changes in genes can cause health problems. Mutations in gene usually end up causing that particular gene copy to not do its job the way it normally should. Since we have two copies of every gene, typically there's still a normal working copy of gene. In these cases, usually nothing out of ordinary happens since the body can still do the jobs it needs to do. This is an example of autosomal recessive trait. For someone to have recessive disease or characteristic, person must have gene mutation in both copies of gene pair, causing the body to not have working copies of that particular gene. Genes can be either dominant or recessive. Dominant genes show their effect even if there is just one mutation in one copy of that gene pair; one mutation dominates the normal back - up copy of the gene, and the characteristic shows itself. People can be born with gene mutations, or they can happen over their lifetime. Mutations can occur when cells are aging or have been exposed to certain chemicals or radiation. Fortunately, cells usually recognize these types of mutations and repair them by themselves. Other times, however, they can cause illnesses, such as some types of cancer. If gene mutations exist in egg or sperm cells, children can inherit gene mutations from their parents. When mutation is in every cell of the body, body is not able to repair gene change.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

What Are Genetic Disorders?

Within the United States, twentieth century was marked by an overall increase in life expectancy of about six years in both men and women, raising the average life span to 74 years in men and almost 80 years in women. Recently, however, mortality seems to be increasing, and it appears to be doing so AT different rates in different areas of the country. For example, counties along the Mississippi River and in Appalachia have shown the most significant decrease in life expectancy. An increase in the incidence of cancer, diabetes, chronic obstructive pulmonary disease, and cardiovascular disease seem to be responsible for this decline, particularly among women. Both marked increase in human life span that occurred in the twentieth century and the recent decline in life expectancy coincide with great advances in the field of genetics. Despite these advances, scientists have yet to unravel complex genetic mechanisms underlying the majority of common disorders, especially those that claim the lives of seemingly healthy adults. Researchers do know that genetic diseases fall into three main causative categories: defects in single gene, mutations in multiple genes, and chromosomal abnormalities. While many genetic diseases manifest after birth, others do not show symptoms until later in life, some 30 to 70 years later. In framework of late - onset disease, researchers know that polygenic disorders outnumber other types by orders of magnitude. Nonetheless, causes of onset and progression of such disorders are poorly understood due to the complexity of genetic mechanisms involve, as well as the interplay between these mechanisms and the environment. Some factors that trigger incurable diseases after decades of healthy life have been propose, however. These factors, as described in sections that follow, help explain reasons for the marked prevalence of polygenetic disorders among the older population. Diverse and deadly list of afflictions can be categorized as late - onset disorders, including numerous cancers, Alzheimer's Disease, and schizophrenia, to name but a few. While some mutations that contribute to these disorders are present AT birth, many more of these mutations arise from intrinsic failures of genomic replication mechanisms within cells. Some of these failures can be traced to mutagens in the environment. In addition to causing mutations, mutagens can also trigger expression of genes already present in the genome that are otherwise dormant. Together, this combination of accumulated harmful mutations and inappropriately activated genes can eventually manifest in pathology. To explore this idea further, consider the example of cancer. While many people are born with genes that increase their chances of developing certain cancers, these people never manifest disease unless specific mutations occur during the course of their lifetime. For instance, mutations in the HPC1 gene on chromosome 1 have been linked to the development of prostate cancer. Although individual with this mutation can develop nonmalignant polyp AT fairly young age, prostate cancer will not metastasize to man's other organs unless the number of other tumor suppressor genes are also partially or completely disabled.


What are Mendelian Disorders?

Gregor Mendel discovered a set of principles of heredity in the mid - 19th century; characteristic patterns of inheritance are determined on the basis of these principles. Single gene disorders arising from errors in DNA sequence of genes are categorized into autosomal dominant, autosomal recessive, X - link recessive, X - link dominant and Y - link disorders. In autosomal dominant disorders, 4, damage in one allele of a pair of genes leads to deficiency Table 1, eg mutation in FGFR3 gene can cause achondroplasia. A parent with autosomal dominant disorder has a 50% chance of transmitting the disease to her / his child. The range of signs and symptoms of some diseases in different people vary widely variable expressivity, eg some people with Marfan syndrome due to mutation in FBN1 have only mild symptoms such as being tall and thin with long, slender fingers, while others have life - threatening complications involving heart and blood vessels as well. Furthermore, some individuals exhibit signs and symptoms of give disorder while others do not, even though they have disease - causing mutation i. E proportion of people with particular mutation show condition in this type of disorders, eg many people having mutation of BRCA1 gene will develop breast cancer during their lifetime, while some people will not. In other words, in pedigree healthy individual has at least one affected parent and one affected child skip generation. Mutations in both alleles loss of function of gene are required to cause defects to appear in autosomal recessive disorder Table 1 and Fig. 1c2, ie affected person has got one abnormal allele from one heterozygous parent. In this type of disorders, there is a 25% chance of having affected offspring for heterozygous parents. In the case of common autosomal recessive disorders or traits, sickle cell anemia due to specific mutation in HBB gene encoding beta globin or nonsyndromic autosomal recessive hearing loss due to mutations in GJB2 gene encoding connexin 26, sometimes homozygous affected person marries heterozygous carrier; such example, in which apparently dominant transmission of this disorder occur, is call pseudodominant inheritance. In X - link disorder Fig. 1c3 and Table 1, mutated gene is located on the X chromosome. Recessive mutation can lead to disease. Genes on chromosome X should be mutated to cause condition; hence, X - link recessive disorder is carried by females, while usually affecting males. Some genetic conditions follow none of the mentioned patterns of inheritance; mitochondrial diseases, trinucleotide expansion disorders and genomic imprinting defects have non - Mendelian or nontraditional pattern of inheritance.


Mutations Are Recessive or Dominant

Many different approaches have been used for identifying known mutations. Usually, starting with polymerase chain reaction, additional assay steps are performed based on type of mutation. Table 5 shows examples of some of frequently used techniques AS well AS their advantages and disadvantages. Here, brief view of some of these techniques is presented with focus on their applications. Polymerase chain reaction and its versions: In the 1980s, Dr Mullis introduced a method for amplifying DNA fragments to large numbers of fragments in only a few hours; this method, named polymerase chain reaction, was a critical point in molecular biology. Essential components of polymerase chain reaction are template DNA, primers, thermostable DNA polymerase enzyme, divalent cations, deoxynucleoside triphosphates and buffer solution. Pcr, consisting of 25 - 40 repeated cycles, has three discrete steps of temperature changes; after single temperature step at high temperature, series of cycles of denaturation, annealing of primers and extension are performed and followed by a single temperature step called final product extension or brief storage. These steps are AS follow: initial denaturation step includes heating reaction to a temperature of 92 - 96C for 1 - 9 minutes. The denaturation step includes heating reaction to 92 - 98C for 20 - 30 seconds. Hydrogen bonds between complementary bases are disrupted and DNA molecules are denature, yielding single - strand DNA molecules. The annealing step is performed by decreasing temperature to 50 - 65C for 25 - 40 seconds; so primers anneal to their targets on single strand DNAs by hydrogen bonds and polymerase can bind to primer - template hybrid and begin DNA polymerization in the next step. The Extension step includes polymerization of bases to primers; thermostable such AS Taq polymerase extend new strand complementary to DNA template strand by adding match dNTPs in 5 to 3 directions at a temperature of 72C. A series of 25 - 40 repeated cycles of denaturation, annealing of primers and extension is performed to amplify template fragment. Subsequently, final elongation is sometimes done at 70 - 74C for 5 - 15 minutes after the last PCR cycle to ensure full extension of any remaining single - strand DNA. Checking PCR products, electrophoresis are used for sizing PCR products by comparison with DNA ladder. Here, applications of some PCR versions are mention. Reverse transcriptase PCR: in this version, strand of RNA molecule is transcribed reversely into its complementary DNA using a reverse transcriptase enzyme. This cDNA is then amplified by PCR. Rt - PCR is applied to study mutations at RNA level. Multiplex PCR: in this technique, multiple selected target regions in sample are amplified simultaneously using different pairs of primers. Nest PCR: It includes two successive PCRs; product of the first PCR reaction is use AS template for the second PCR. This type of PCR is used to amplify templates in low copy numbers in specimens. It has benefits of increased sensitivity and specificity.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

Sources

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions.

* Please keep in mind that all text is machine-generated, we do not bear any responsibility, and you should always get advice from professionals before taking any actions

logo

Plex.page is an Online Knowledge, where all the summaries are written by a machine. We aim to collect all the knowledge the World Wide Web has to offer.

Partners:
Nvidia inception logo

© All rights reserved
2021 made by Algoritmi Vision Inc.

If you believe that any of the summaries on our website lead to misinformation, don't hesitate to contact us. We will immediately review it and remove the summaries if necessary.

If your domain is listed as one of the sources on any summary, you can consider participating in the "Online Knowledge" program, if you want to proceed, please follow these instructions to apply.
However, if you still want us to remove all links leading to your domain from Plex.page and never use your website as a source, please follow these instructions.